Power Law company profile

Orna Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2019 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Investors

11 investors on Orna Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 9 investors entered at this stage

Series B+ 2 investors entered at this stage

BioImpact Capital

Merck & Co.

Global footprint

Where Orna Therapeutics has talent and traffic

AI talent share

0.6% of workforce is AI talent
(1 of 172 staff)

Core AI10.58%

Other AI00%

Non-AI workforce17199.42%

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States64.5%

🇬🇧 United Kingdom14.5%

🇮🇳 India11.8%

🇮🇹 Italy4.5%

🇭🇰 Hong Kong0.9%

Top 5 markets shown

Patent intelligence

$5M patent portfolio · 15 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$5M

0.31% of valuation · 43.1× the top peer Capstan Therapeutics ($108k)

15 active patent families

Where Orna Therapeutics innovates NanoparticlePolynucleotideCircular RNANucleotideMolecular biology

Below peer median on Legal, Strategic, Market

Quality vs same-sector peers

Orna Therapeutics on the five Patsnap quality dimensions

Orna Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Orna Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Orna Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Orna Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo